iRhythm Technologies, Inc.

NasdaqGS:IRTC 주식 보고서

시가총액: US$3.3b

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

iRhythm Technologies 관리

관리 기준 확인 2/4

iRhythm Technologies' CEO는 Quentin Blackford, Oct2021 에 임명되었습니다 의 임기는 2.67 년입니다. 총 연간 보상은 $ 16.60M, 4.1% 로 구성됩니다. 4.1% 급여 및 95.9% 보너스(회사 주식 및 옵션 포함). 는 $ 7.10M 가치에 해당하는 회사 주식의 0.23% 직접 소유합니다. 7.10M. 경영진과 이사회의 평균 재임 기간은 각각 2 년과 6.9 년입니다.

주요 정보

Quentin Blackford

최고 경영자

US$16.6m

총 보상

CEO 급여 비율4.1%
CEO 임기2.7yrs
CEO 소유권0.2%
경영진 평균 재임 기간2yrs
이사회 평균 재임 기간6.9yrs

최근 관리 업데이트

Recent updates

iRhythm Technologies (NASDAQ:IRTC) Is Carrying A Fair Bit Of Debt

May 13
iRhythm Technologies (NASDAQ:IRTC) Is Carrying A Fair Bit Of Debt

iRhythm Technologies, Inc.'s (NASDAQ:IRTC) Business Is Trailing The Industry But Its Shares Aren't

Mar 25
iRhythm Technologies, Inc.'s (NASDAQ:IRTC) Business Is Trailing The Industry But Its Shares Aren't

Here's What Analysts Are Forecasting For iRhythm Technologies, Inc. (NASDAQ:IRTC) After Its Annual Results

Feb 25
Here's What Analysts Are Forecasting For iRhythm Technologies, Inc. (NASDAQ:IRTC) After Its Annual Results

iRhythm Technologies (NASDAQ:IRTC) Has Debt But No Earnings; Should You Worry?

Feb 02
iRhythm Technologies (NASDAQ:IRTC) Has Debt But No Earnings; Should You Worry?

iRhythm Technologies, Inc. (NASDAQ:IRTC) Shares Could Be 30% Below Their Intrinsic Value Estimate

Dec 20
iRhythm Technologies, Inc. (NASDAQ:IRTC) Shares Could Be 30% Below Their Intrinsic Value Estimate

iRhythm Technologies, Inc. (NASDAQ:IRTC) Stocks Shoot Up 25% But Its P/S Still Looks Reasonable

Dec 20
iRhythm Technologies, Inc. (NASDAQ:IRTC) Stocks Shoot Up 25% But Its P/S Still Looks Reasonable

Is Now An Opportune Moment To Examine iRhythm Technologies, Inc. (NASDAQ:IRTC)?

Dec 02
Is Now An Opportune Moment To Examine iRhythm Technologies, Inc. (NASDAQ:IRTC)?

Health Check: How Prudently Does iRhythm Technologies (NASDAQ:IRTC) Use Debt?

Sep 20
Health Check: How Prudently Does iRhythm Technologies (NASDAQ:IRTC) Use Debt?

iRhythm Technologies, Inc. (NASDAQ:IRTC) Shares Could Be 25% Below Their Intrinsic Value Estimate

Aug 30
iRhythm Technologies, Inc. (NASDAQ:IRTC) Shares Could Be 25% Below Their Intrinsic Value Estimate

When Should You Buy iRhythm Technologies, Inc. (NASDAQ:IRTC)?

Jul 04
When Should You Buy iRhythm Technologies, Inc. (NASDAQ:IRTC)?

Is iRhythm Technologies (NASDAQ:IRTC) Using Debt In A Risky Way?

Jun 16
Is iRhythm Technologies (NASDAQ:IRTC) Using Debt In A Risky Way?

Estimating The Intrinsic Value Of iRhythm Technologies, Inc. (NASDAQ:IRTC)

May 26
Estimating The Intrinsic Value Of iRhythm Technologies, Inc. (NASDAQ:IRTC)

iRhythm Technologies, Inc.'s (NASDAQ:IRTC) P/S Is On The Mark

May 08
iRhythm Technologies, Inc.'s (NASDAQ:IRTC) P/S Is On The Mark

What Does iRhythm Technologies, Inc.'s (NASDAQ:IRTC) Share Price Indicate?

Mar 27
What Does iRhythm Technologies, Inc.'s (NASDAQ:IRTC) Share Price Indicate?

Is iRhythm Technologies (NASDAQ:IRTC) Using Debt Sensibly?

Feb 25
Is iRhythm Technologies (NASDAQ:IRTC) Using Debt Sensibly?

Health Check: How Prudently Does iRhythm Technologies (NASDAQ:IRTC) Use Debt?

Nov 24
Health Check: How Prudently Does iRhythm Technologies (NASDAQ:IRTC) Use Debt?

iRhythm falls after reaffirming 2022 guidance

Sep 21

iRhythm: Fairly Priced At Current Multiples, No Need To Size Up

Sep 02

Is iRhythm Technologies (NASDAQ:IRTC) Using Debt In A Risky Way?

Aug 18
Is iRhythm Technologies (NASDAQ:IRTC) Using Debt In A Risky Way?

iRhythm Technologies Q2 results beat estimates, co raises FY 2022 revenue guidance

Aug 04

iRhythm Technologies provides FY22 prelims, commercial chief resigns

Jul 19

iRhythm: Reimbursement Overhang Squashed, Bull Thesis Back Intact

Jun 08

Is iRhythm Technologies (NASDAQ:IRTC) A Risky Investment?

Apr 14
Is iRhythm Technologies (NASDAQ:IRTC) A Risky Investment?

CEO 보상 분석

Quentin Blackford 의 보수는 iRhythm Technologies 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Mar 31 2024n/an/a

-US$130m

Dec 31 2023US$17mUS$677k

-US$123m

Sep 30 2023n/an/a

-US$105m

Jun 30 2023n/an/a

-US$99m

Mar 31 2023n/an/a

-US$105m

Dec 31 2022US$8mUS$650k

-US$116m

Sep 30 2022n/an/a

-US$128m

Jun 30 2022n/an/a

-US$131m

Mar 31 2022n/an/a

-US$124m

Dec 31 2021US$10mUS$163k

-US$101m

보상 대 시장: Quentin 의 총 보상 ($USD 16.60M )은 US 시장( $USD 6.80M ).

보상과 수익: 회사가 수익성이 없는 동안 Quentin 의 보상이 증가했습니다.


CEO

Quentin Blackford (45 yo)

2.7yrs

테뉴어

US$16,595,149

보상

Mr. Quentin S. Blackford serves as an Independent Director of Paragon 28, Inc. since August 1, 2022. He serves as President and Chief Executive Officer since October 04, 2021 and serves as Director at iRhy...


리더십 팀

이름위치테뉴어보상소유권
Quentin Blackford
President2.7yrsUS$16.60m0.23%
$ 7.6m
Brice Bobzien
Chief Financial Officer1.8yrsUS$5.28m0.0085%
$ 279.2k
Minang Turakhia
Chief Medical & Scientific Officer and Executive VP of Product Innovation2.2yrsUS$5.32m0.011%
$ 365.8k
Patrick Murphy
Chief Business & Legal Officer2.5yrsUS$5.33m0.031%
$ 1.0m
Chad Patterson
Chief Commercial Officer1.9yrsUS$5.77m0.017%
$ 561.8k
Mervin Smith
Executive Vice President of Business Operationsless than a year데이터 없음데이터 없음
Marc Rosenbaum
Senior VP of Finance & Chief Accounting Officerless than a year데이터 없음0.0029%
$ 95.7k
Daniel Wilson
Executive VP of Corporate Development & Investor Relations5yrsUS$3.54m0.098%
$ 3.2m
Douglas Devine
Executive Advisor1.3yrsUS$2.72m0.055%
$ 1.8m
Sumi Shrishrimal
Executive VP & Chief Risk Officer2.1yrs데이터 없음0.075%
$ 2.5m
Stephanie Zhadkevich
Director of Investor Relationsno data데이터 없음데이터 없음

2.0yrs

평균 재임 기간

45yo

평균 연령

경험이 풍부한 관리: IRTC 의 관리팀은 경험 ( 2 년 평균 재직 기간)으로 간주됩니다.


이사회 구성원

이름위치테뉴어보상소유권
Quentin Blackford
President2.4yrsUS$16.60m0.23%
$ 7.6m
Ralph Snyderman
Independent Director6.9yrsUS$233.12k0.032%
$ 1.1m
Michael Mirro
Medical Director & Member of Scientific Advisory Boardno data데이터 없음데이터 없음
Bruce Bodaken
Independent Director6.9yrsUS$240.25k0.030%
$ 994.7k
Abhijit Talwalkar
Independent Chairman8.1yrsUS$286.74k0.034%
$ 1.1m
R. Mead
Medical Director & Member of Scientific Advisory Boardno data데이터 없음데이터 없음
James Quinn
Member of Scientific Advisory Boardno data데이터 없음데이터 없음
Cathleen Noel Merz
Independent Director6.2yrsUS$230.62k0.019%
$ 608.3k
Mark Rubash
Independent Director8.3yrsUS$248.12k0.034%
$ 1.1m
Mehdi Razavi
Medical Director & Member of Scientific Advisory Boardno data데이터 없음데이터 없음
Karen Ling
Independent Director2.6yrsUS$239.97k0.020%
$ 671.2k
Jay Alexander
Medical Director & Member of Scientific Advisory Boardno data데이터 없음데이터 없음

6.9yrs

평균 재임 기간

67yo

평균 연령

경험이 풍부한 이사회: IRTC 의 이사회경험(평균 재직 기간 6.9 년)으로 간주됩니다.